Junichi Asano

Master protocol trials in oncology: Review and new trial designs

Akihiro Hirakawa, Junichi Asano, Hiroyuki Sato et al. · Contemporary Clinical Trials Communications · 2018 · 114 citations · Full text

Cancer Management, Clinical Endpoint, Pathology +19

Epidemiology of Progressive Muscular Dystrophy in Okinawa, Japan

Masanori Nakagawa, Keiichi Nakahara, Hiroaki Yoshidome et al. · Neuroepidemiology · 1991 · 40 citations

Assessing the prediction accuracy of cure in the Cox proportional hazards cure model: an application to breast cancer data

Junichi Asano, Akihiro Hirakawa, Chikuma Hamada · Pharmaceutical Statistics · 2014 · 29 citations

Surgical Oncology, Cancer Management, Epidemiology Of Cancer +17

A practical approach to non-natural or N-unsubstituted α-arylglycine derivatives: Hf(OTf)4-doped Me3SiCl system-catalyzed aminomethylation of electron-rich arenes with a new type of N,O-acetal

Norio Sakai, Junichi Asano, Yuta Shimano et al. · Tetrahedron · 2008 · 26 citations

Derivatives, Electron-rich Arenes, Biochemistry +9

Regulatory Issues: PMDA – Review of Sakigake Designation Products: Oncolytic Virus Therapy with Delytact Injection (Teserpaturev) for Malignant Glioma

Yoshiaki Maruyama, Akira Sakurai, Shinichi Noda et al. · The Oncologist · 2023 · 26 citations · Full text